Public Employees Retirement System of Ohio Acquires Shares of 43,561 Merit Medical Systems, Inc. $MMSI

Key Points

• Public Employees Retirement System of Ohio purchased 43,561 Merit Medical Systems shares worth approximately $3.02 million, giving it a 0.07% stake. Institutional investors collectively own 99.66% of the company.
• Merit Medical reported quarterly EPS of $1.19, beating estimates of $0.96, while revenue rose 9.5% year over year to $418.84 million. The company issued fiscal 2026 EPS guidance of $4.25–$4.35.
• Analyst sentiment is positive, with a consensus “Moderate Buy” rating and an average price target of $100, compared with the stock’s reported opening price of $89.60.

Public Employees Retirement System of Ohio bought a new stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 43,561 shares of the medical instruments supplier's stock, valued at approximately $3,021,000. Public Employees Retirement System of Ohio owned about 0.07% of Merit Medical Systems at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the stock. Los Angeles Capital Management LLC acquired a new stake in Merit Medical Systems in the fourth quarter valued at $25,000. Kilter Group LLC acquired a new position in Merit Medical Systems during the 2nd quarter worth $25,000. Covestor Ltd increased its position in shares of Merit Medical Systems by 252.6% in the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier's stock worth $41,000 after purchasing an additional 336 shares during the last quarter. Danske Bank A S acquired a new stake in shares of Merit Medical Systems in the 3rd quarter valued at about $42,000. Finally, Quarry LP raised its stake in shares of Merit Medical Systems by 185.9% in the 3rd quarter. Quarry LP now owns 526 shares of the medical instruments supplier's stock valued at $44,000 after purchasing an additional 342 shares in the last quarter. Institutional investors and hedge funds own 99.66% of the company's stock.

Merit Medical Systems Price Performance

Shares of MMSI opened at $89.60 on Friday. Merit Medical Systems, Inc. has a 12 month low of $59.74 and a 12 month high of $94.75. The company has a debt-to-equity ratio of 0.44, a current ratio of 4.20 and a quick ratio of 2.79. The stock has a fifty day moving average price of $81.85 and a 200 day moving average price of $73.22. The company has a market cap of $5.35 billion, a P/E ratio of 37.02, a PEG ratio of 2.21 and a beta of 0.49.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last posted its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The company had revenue of $418.84 million for the quarter, compared to analysts' expectations of $405.25 million. During the same period last year, the business posted $1.01 earnings per share. The firm's quarterly revenue was up 9.5% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. On average, research analysts forecast that Merit Medical Systems, Inc. will post 3.84 earnings per share for the current year.

Wall Street Analyst Weigh In

MMSI has been the subject of a number of research reports. Weiss Ratings upgraded Merit Medical Systems from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, August 18th. JPMorgan Chase & Co. increased their target price on Merit Medical Systems from $77.00 to $95.00 and gave the stock an "overweight" rating in a report on Friday, July 31st. Raymond James Financial reiterated an "outperform" rating and issued a $100.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. Wells Fargo & Company raised their price objective on Merit Medical Systems from $74.00 to $83.00 and gave the stock an "equal weight" rating in a research note on Friday, July 31st. Finally, Bank of America boosted their target price on shares of Merit Medical Systems from $92.00 to $97.00 and gave the company a "neutral" rating in a research note on Thursday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $100.00.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source